CD4 and COVID-19: When SARS-CoV-2 vaccines were rolled out, PLWH—especially those with current CD4 + T-cell count < 200/μL, evidence of an opportunistic infection, and/or with a detectable viral load—were prioritized for vaccination, due to the potential higher risk for worse COVID-19 outcomes [78].